Survivors of early-stage breast cancer may report treatment-related side effects that persist
for several years after the end of primary treatment. Among these, fatigue and cognitive …

Behavioral comorbidities (depression, anxiety, fatigue, cognitive disturbances, and
neuropathic pain) are prevalent in cancer patients and survivors. These mental and …

The Coronavirus disease 2019 (COVID-19) outbreak generated an unprecedented set of
emotional challenges for women diagnosed with breast cancer. In the United Kingdom (UK) …

Background: Cancer patients, being immunocompromised, are at higher risk of coronavirus
disease (COVID-19). The current study determines cancer patients' knowledge, attitude …

Purpose: Pennyroyal is a species of the Lamiaceae family with potent anti-cancer and
antioxidant properties. Combining this antioxidant with chemotherapeutic agents enhances …

Prolonged inflammatory expression within the central nervous system (CNS) is recognized
by the brain as a molecular signal of “sickness”, that has knock‐on effects to the blood–brain …

Objectives Breast cancer enhances anxiety and depressive vulnerability, profoundly
impairing the quality of life in survivors. Hinging on recent research that training attentional …

To investigate chemotherapy dosage-related cognitive impairment and its neural
mechanisms in breast cancer (BC) patients. Twenty-eight breast cancer patients after each …

This study aims to disclose how the magnetic resonance imaging (MRI) neuroimaging
approach has been applied in education studies, and what kind of learning themes has …

Purpose The purpose of this study was to evaluate longitudinal changes in brain gray matter
density (GMD) before and after adjuvant chemotherapy in older women with breast cancer …